F18.17

Clinical Causes: Frequent inhalation of volatile substances such as solvent glues, aerosols, paints, and cleaning products. Use of inhalants primarily among adolescents and young adults seeking quick euphoria or escape from stress. Prolonged abuse leading to neurotoxic effects that damage brain cells and neural pathways. Lack of awareness about the harmful effects of inhalants, especially in youth environments. Co-occurring mental health conditions like depression or anxiety that may encourage substance misuse.

Key Symptoms: Memory loss and difficulty forming new memories. Problems with attention, concentration, and decision-making. Altered mental state, confusion, or disorientation. Incoordination and difficulties with motor skills. Personality changes, such as increased irritability or depression. Physical signs such as tremors, unsteady gait, or slurred speech. Decreased motivation or interest in usual activities.

Diagnosis Path: Diagnosis involves a detailed medical history, including questions about substance use. Healthcare providers may use cognitive tests, neurological examinations, and neurological imaging to assess brain function and identify any damage. Blood and urine tests might help confirm recent inhalant use. Recognizing patterns of inhalant use and their symptoms is crucial for diagnosing inhalant-induced dementia. Medical professionals also evaluate comorbid mental health conditions that could influence treatment approaches.

Treatment Protocols: Detoxification and withdrawal management under medical supervision. Psychotherapy, such as cognitive-behavioral therapy (CBT), to address substance abuse habits. Support groups and counseling to foster recovery and prevent relapse. Rehabilitation programs geared toward improving cognitive function and daily skills. Monitoring and managing any physical health issues resulting from inhalant abuse. Long-term psychological support to cope with emotional and mental health challenges.